SCED - Wisdom Enhancement for Post-Stroke Depression
United Kingdom3 participantsStarted 2023-09-01
Plain-language summary
One-third of stroke survivors experience post-stroke depression, but there are currently no official guidelines for supporting them. Researchers aim to investigate whether the wisdom enhancement timeline technique can reduce depression in stroke survivors. The investigators also want to understand how this technique positively impacts mood, identity, self-esteem, and wisdom. The study will involve nine stroke survivors from the National Health Service (NHS) to gain insights into effective ways to support those with post-stroke depression.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Had a stroke.
* Those who self-report as having difficulties with depression to a clinician.
* Have sufficient cognitive and communication abilities for informed consent and active engagement
Exclusion Criteria:
* Under the age of 18. Because this is the age when they are treated as an adult by UK law.
* Severe cognitive impairments or mental health difficulties that would hinder task engagement or provide informed consent.
* Medical instability jeopardising consistent participation or well-being.
* Significant risk concerns regarding safety to themselves or others.
* Substance use/dependency impacting adherence.
* Prescribed psychotropic medication less than 3 months ago.
* Currently involved in research.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Visual Analogue Scale (VAS) - Mood
Timeframe: Daily during baseline phase and intervention phase (total of 8-10 weeks depending on baseline length)
2
Visual Analogue Scale (VAS) - Identity
Timeframe: Daily during baseline phase and intervention phase (total of 8-10 weeks depending on baseline length)
3
Visual Analogue Scale (VAS) - Wisdom
Timeframe: Daily during baseline phase and intervention phase (total of 8-10 weeks depending on baseline length)
4
Visual Analogue Scale (VAS) - Self-esteem
Timeframe: Daily during baseline phase and intervention phase (total of 8-10 weeks depending on baseline length)